表紙
市場調查報告書

尿液檢查的全球市場 - 至2024年的預測:測試紙,妊娠檢測套組,試劑,消耗品,自動、半自動、POC分析儀

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 327838
出版日期 內容資訊 英文 147 Pages
訂單完成後即時交付
價格
Back to Top
尿液檢查的全球市場 - 至2024年的預測:測試紙,妊娠檢測套組,試劑,消耗品,自動、半自動、POC分析儀 Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024
出版日期: 2019年03月29日內容資訊: 英文 147 Pages
簡介

全球尿液檢查市場將從2019年的32億美元,擴大到2024年到46億美元。市場在2019年∼2024年間,預計將以年複合成長率 (CAGR) 7.6%的速度成長。

本報告提供全球尿液檢查市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 尿液檢查:市場概要
  • 北美 - 尿液檢查市場:各產品
  • 尿液檢查市場各地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 機會
    • 課題

第6章 尿液檢查的全球市場:各產品

  • 簡介
  • 消耗品
  • 設備

第7章 尿液檢查的全球市場:各檢驗類型

  • 簡介
  • 妊娠檢驗
  • 尿生物化學檢驗
  • 尿沈渣檢驗

第8章 尿液檢查的全球市場:各用途

  • 簡介
  • 疾病的篩檢
  • 妊娠檢驗

第9章 尿液檢查的全球市場:各終端用戶

  • 簡介
  • 醫院、診所
  • 臨床檢驗室
  • 居家醫療
  • 研究所、機關

第10章 尿液檢查的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第11章 競爭情形

  • 概要
  • 市場佔有率分析
  • 主要策略
  • 競爭領導製圖

第12章 企業簡介

  • CARDINAL HEALTH, INC.
  • ALERE, INC. (ABBOTT LABORATORIES的一部分)
  • SIEMENS HEALTHINEERS
  • ROCHE DIAGNOSTICS
  • BECKMAN COULTER INC. (DANAHER CORPORATION的子公司)
  • SYSMEX CORPORATION
  • QUIDEL CORPORATION
  • BIO-RAD LABORATORIES, INC.
  • ARKRAY, INC.
  • ACON LABORATORIES, INC.
  • 77 ELEKTRONIKA KFT
  • URIT MEDICAL ELECTRONIC GROUP CO., LTD.
  • DIRUI INDUSTRIAL CO., LTD.

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 3259

"Urinalysis market to register a CAGR of 7.6% from 2019 to 2024"

The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024. The growth of the market is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis. Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market.

"Consumables accounted for a significant share of the market in 2019"

By product, the urinalysis market is segmented into consumables and instruments. The consumables segment includes pregnancy and fertility kits, dipsticks, reagents, and disposables, while the instruments segment includes automated urine analyzers, semi-automated urine analyzers, and point-of-care urine analyzers. The consumables segment dominated the market and is the fastest growing segment due to rising incidence of urinary tract infections and kidney diseases which creates the demand for regular urine checkups.

"Pregnancy and fertility tests segment accounted for the largest share of the urinalysis market in 2019"

The urinalysis market, by test type, is segmented into biochemical urinalysis, sediment urinalysis, and pregnancy & fertility tests. The pregnancy & fertility tests segment is estimated to account for the largest share of the urinalysis market in 2019 while the sediment urinalysis segment is estimated to witness the highest growth rate during the forecast period. The rising incidence of UTIs and kidney diseases and the shift towards automation are the major factors driving the growth of this segment.

"Disease screening segment accounted for the largest share of the urinalysis market in 2019"

On the basis of application, the urinalysis market is segmented into disease screening and pregnancy & fertility. In the disease screening segment, UTIs have the largest market share. Urine analysis has become a part of the general check-up in many countries and is used as a preliminary technique for screening for UTIs and other kidney diseases. This is followed by high throughput technique for diagnosing the diseases.

"Hospitals and clinics segment accounted for the largest share of the urinalysis market in 2019"

On the basis of end user, the urinalysis market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, and research laboratories & institutes. Of all these end-user segments, hospitals & clinics accounted for the largest share of the urinalysis market in 2019. The large share of this segment can be attributed to factors such as the rapidly growing aging population, the increasing global incidence of kidney diseases and UTIs, increase in reimbursements for clinical tests performed in hospitals among others.

"North America dominated the urinalysis market in 2019"

North America, which includes the US, & Canada, accounted for the largest share of the urinalysis market. The growth in this market is primarily driven by the increasing prevalence of UTIs and kidney diseases, rising geriatric population, favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and availability of technologically advanced urinalysis instruments in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), Asia (25%), and RoW (16%)

The major players operating in this market are: Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Bio-Rad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US) and URIT Medical Electronic Ltd. (China). Product launches, partnerships and acquisitions are the key growth strategies followed by most players in this market.

Research Coverage:

This report studies the urinalysis market based on product, test type, application end user and region. The report also analyzes factors (such as drivers, restraints and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total urinalysis market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on urinalysis offered by the top 13 players in the urinalysis market. The report analyzes the urinalysis market by type, application, and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various urinalysis across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urinalysis market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the urinalysis market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 MARKETS COVERED
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 SECONDARY DATA
    • 2.1.1 KEY DATA FROM SECONDARY SOURCES
  • 2.2 PRIMARY DATA
    • 2.2.1 KEY DATA FROM PRIMARY SOURCES
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 URINALYSIS: MARKET OVERVIEW
  • 4.2 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT (2019)
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE URINALYSIS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing global prevalence of kidney diseases and urinary tract infections
      • 5.2.1.2 Shift towards automation in sediment analysis
      • 5.2.1.3 Increasing adoption of point-of-care urinalysis
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Integrated systems for urinalysis
      • 5.2.2.2 Emerging economies
    • 5.2.3 CHALLENGES
      • 5.2.3.1 High cost of automated analyzers affecting market penetration in emerging economies

6 URINALYSIS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    • 6.2.1 PREGNANCY & FERTILITY KITS
      • 6.2.1.1 Need for rapid pregnancy testing to drive market growth
    • 6.2.2 DIPSTICKS
      • 6.2.2.1 Dipsticks are used regularly due to their low cost and ease of use
    • 6.2.3 DISPOSABLES
      • 6.2.3.1 Wide usage of urine collection cups will drive the market for disposables
    • 6.2.4 REAGENTS
      • 6.2.4.1 Increasing use of controls and calibrators to drive market growth
  • 6.3 INSTRUMENTS
    • 6.3.1 AUTOMATED URINE ANALYZERS
      • 6.3.1.1 Biochemical urine analyzers
        • 6.3.1.1.1 Increasing incidence of kidney diseases and urinary tract infections will increase the demand for automated biochemical analyzers
      • 6.3.1.2 Sediment urine analyzers
        • 6.3.1.2.1 Microscopy analyzers
        • 6.3.1.2.1.1 Increased adoption of automated microscopy analyzers to drive market growth
        • 6.3.1.2.2 Flow cytometry analyzers
        • 6.3.1.2.2.1 Accuracy and sensitivity of flow cytometry technique to drive the adoption of these analyzers
      • 6.3.1.3 Integrated urine analyzers
        • 6.3.1.3.1 Higher workload in hospitals and laboratories to drive the adoption of integrated systems
    • 6.3.2 SEMI-AUTOMATED URINE ANALYZERS
      • 6.3.2.1 Semi-automated urine analyzers are used extensively due to their low cost and ease of use
    • 6.3.3 POINT-OF-CARE URINE ANALYZERS
      • 6.3.3.1 Need for rapid testing to drive the demand for PoC devices

7 URINALYSIS MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
  • 7.2 PREGNANCY & FERTILITY TESTS
    • 7.2.1 RISING INCIDENCE OF ACCIDENTAL PREGNANCIES TO DRIVE THE GROWTH OF THIS SEGMENT
  • 7.3 BIOCHEMICAL URINALYSIS
    • 7.3.1 LABORATORY TESTS
      • 7.3.1.1 Increasing incidence of urinary tract infections and kidney diseases to drive the growth of this segment
    • 7.3.2 POINT-OF-CARE TESTS
      • 7.3.2.1 Ease and convenience of poc testing to drive the growth of this segment during the forecast period
  • 7.4 SEDIMENT URINALYSIS
    • 7.4.1 INCREASING ADOPTION OF AUTOMATED ANALYZERS TO DRIVE THE GROWTH OF THIS SEGMENT

8 URINALYSIS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 DISEASE SCREENING
    • 8.2.1 URINARY TRACT INFECTIONS
      • 8.2.1.1 Increasing prevalence of UTIs to drive growth in the urinalysis market for disease screening
    • 8.2.2 KIDNEY DISEASES
      • 8.2.2.1 Rapidly growing global geriatric population and the subsequent increase in the prevalence of kidney diseases to drive market growth
    • 8.2.3 DIABETES
      • 8.2.3.1 Development of advanced analytical tools for diabetes will drive market growth
    • 8.2.4 LIVER DISEASES
      • 8.2.4.1 High prevalence of liver diseases will increase the demand for urinalysis
    • 8.2.5 OTHER DISEASE SCREENING APPLICATIONS
  • 8.3 PREGNANCY & FERTILITY
    • 8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY & FERTILITY TO DRIVE GROWTH IN THE URINALYSIS MARKET

9 URINALYSIS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS & CLINICS
    • 9.2.1 INCREASE IN HOSPITALIZATIONS FOR URINARY DISEASES TO DRIVE GROWTH IN THIS END-USER SEGMENT
  • 9.3 DIAGNOSTIC LABORATORIES
    • 9.3.1 LARGE NUMBER OF DIAGNOSTIC LABORATORIES CARRYING OUT TESTS GLOBALLY TO DRIVE MARKET GROWTH
  • 9.4 HOME CARE SETTINGS
    • 9.4.1 WIDESPREAD USE OF PREGNANCY KITS IN HOME CARE SETTINGS TO DRIVE MARKET GROWTH
  • 9.5 RESEARCH LABORATORIES & INSTITUTES
    • 9.5.1 RESEARCH IN DEVELOPING NEW URINALYSIS KITS FOR DISEASE DIAGNOSIS WILL DRIVE MARKET GROWTH

10 URINALYSIS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 US dominates the North American urinalysis market
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing awareness about UTIs will drive market growth in Canada
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany dominates the European urinalysis market
    • 10.3.2 UK
      • 10.3.2.1 UK to register the highest growth in the European market during the forecast period
    • 10.3.3 FRANCE
      • 10.3.3.1 Favorable demographics will support the adoption of urinalysis equipment in France
    • 10.3.4 ITALY
      • 10.3.4.1 Large geriatric population to drive the growth of the urinalysis market in Italy
    • 10.3.5 SPAIN
      • 10.3.5.1 Prevalence of CKD in Spain to drive the demand for urinalysis
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 China accounts for the largest share of the APAC market
    • 10.4.2 JAPAN
      • 10.4.2.1 Well-developed healthcare system and universal healthcare reimbursement policy will ensure steady market growth
    • 10.4.3 INDIA
      • 10.4.3.1 Increasing incidence of CKD is driving market growth
    • 10.4.4 REST OF APAC
  • 10.5 REST OF THE WORLD

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 MARKET RANKING ANALYSIS, 2018
  • 11.3 KEY STRATEGIES
    • 11.3.1 PRODUCT LAUNCHES, 2016-2018
    • 11.3.2 EXPANSIONS, 2016-2018
    • 11.3.3 PARTNERSHIPS, 2016-2018
  • 11.4 COMPETITIVE LEADERSHIP MAPPING (2018)
    • 11.4.1 VENDOR INCLUSION CRITERIA
    • 11.4.2 VISIONARY LEADERS
    • 11.4.3 INNOVATORS
    • 11.4.4 DYNAMIC DIFFERENTIATORS
    • 11.4.5 EMERGING COMPANIES
  • 11.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2018)
    • 11.5.1 PROGRESSIVE COMPANIES
    • 11.5.2 STARTING BLOCKS
    • 11.5.3 RESPONSIVE COMPANIES
    • 11.5.4 DYNAMIC COMPANIES

12 COMPANY PROFILES

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1 CARDINAL HEALTH, INC.
  • 12.2 ALERE, INC. (A PART OF ABBOTT LABORATORIES)
  • 12.3 SIEMENS HEALTHINEERS
  • 12.4 ROCHE DIAGNOSTICS
  • 12.5 BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORPORATION)
  • 12.6 SYSMEX CORPORATION
  • 12.7 QUIDEL CORPORATION
  • 12.8 BIO-RAD LABORATORIES, INC.
  • 12.9 ARKRAY, INC.
  • 12.10 ACON LABORATORIES, INC.
  • 12.11 77 ELEKTRONIKA KFT
  • 12.12 URIT MEDICAL ELECTRONIC GROUP CO., LTD.
  • 12.13 DIRUI INDUSTRIAL CO., LTD.

Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 INSIGHTS OF INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 2: URINALYSIS CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 3: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 4: URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: URINALYSIS DIPSTICKS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: URINALYSIS DISPOSABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: URINALYSIS REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: URINALYSIS INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 10: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 11: AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: AUTOMATED SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 14: SEDIMENT URINE ANALYZERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: AUTOMATED MICROSCOPY ANALYZERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: FLOW CYTOMETRY ANALYZERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: INTEGRATED URINE ANALYZERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 21: PREGNANCY & FERTILITY TESTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 23: BIOCHEMICAL URINALYSIS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: SEDIMENT URINALYSIS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 28: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 29: URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31: URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: URINALYSIS MARKET FOR DIABETES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 33: URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: URINALYSIS MARKET FOR PREGNANCY & FERTILITY, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 37: URINALYSIS END-USER MARKET, BY PRODUCT, 2018 (USD MILLION)
  • TABLE 38: URINALYSIS END-USER MARKET, BY APPLICATION, 2018 (USD MILLION)
  • TABLE 39: URINALYSIS END-USER MARKET, BY TEST TYPE, 2018 (USD MILLION)
  • TABLE 40: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 41: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 42: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 43: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 44: URINALYSIS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 45: NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 46: NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 47: NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 48: NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 49: NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 50: NORTH AMERICA: URINALYSIS END-USER MARKET, BY PRODUCT, 2018 (USD MILLION)
  • TABLE 51: NORTH AMERICA: URINALYSIS END-USER MARKET, BY APPLICATION, 2018 (USD MILLION)
  • TABLE 52: US: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 53: US: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 54: US: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 55: US: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 56: CANADA: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 57: CANADA: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 58: CANADA: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 59: CANADA: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 60: EUROPE: URINALYSIS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 61: EUROPE: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 62: EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 63: EUROPE: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 64: EUROPE: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 65: EUROPE: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
  • TABLE 66: EUROPE: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
  • TABLE 67: GERMANY: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 68: GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 69: GERMANY: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 70: GERMANY: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 71: UK: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 72: UK: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 73: UK: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 74: UK: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 75: FRANCE: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 76: FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 77: FRANCE: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 78: FRANCE: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 79: ITALY: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 80: ITALY: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 81: ITALY: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 82: ITALY: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 83: SPAIN: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 84: SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 85: SPAIN: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 86: SPAIN: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 87: ROE: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 88: ROE: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 89: ROE: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 90: ROE: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 91: APAC: URINALYSIS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 92: APAC: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 93: APAC: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 94: APAC: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 95: APAC: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 96: APAC: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
  • TABLE 97: APAC: URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION)
  • TABLE 98: CHINA: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 99: CHINA: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 100: CHINA: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 101: CHINA: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 102: JAPAN: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 103: JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 104: JAPAN: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 105: JAPAN: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 106: INDIA: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 107: INDIA: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 108: INDIA: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 109: INDIA: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 110: ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 111: ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 112: ROAPAC: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 113: ROAPAC: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 114: ROW: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 115: ROW: URINALYSIS MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
  • TABLE 116: ROW: URINALYSIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 117: ROW: URINALYSIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 118: ROW: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION)
  • TABLE 119: ROW: URINALYSIS END USER MARKET BY APPLICATION, 2018 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: URINALYSIS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: URINALYSIS MARKET: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: URINALYSIS MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
  • FIGURE 7: URINALYSIS MARKET, BY TEST TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: URINALYSIS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: URINALYSIS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: URINALYSIS MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: RISING GLOBAL INCIDENCE OF UTIS AND KIDNEY DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: CONSUMABLES DOMINATED THE NORTH AMERICAN URINALYSIS MARKET IN 2019
  • FIGURE 13: COUNTRIES IN ASIA TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: URINALYSIS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: GROWING AGING POPULATION, BY REGION, 2015 VS. 2030
  • FIGURE 16: CONSUMABLES SEGMENT TO WITNESS HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: PREGNANCY & FERTILITY TESTS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2018
  • FIGURE 18: DISEASE SCREENING APPLICATIONS TO DOMINATE THE URINALYSIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: HOSPITALS & CLINICS TO DOMINATE THE URINALYSIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: APAC TO WITNESS THE HIGHEST GROWTH IN THE URINALYSIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
  • FIGURE 22: POPULATION GROWTH IN THE US, 2016-2060
  • FIGURE 23: APAC: URINALYSIS MARKET SNAPSHOT
  • FIGURE 24: KEY DEVELOPMENTS IN THE URINALYSIS MARKET FROM 2016 TO 2019
  • FIGURE 25: BIOCHEMICAL URINALYSIS
  • FIGURE 26: SEDIMENT URINALYSIS
  • FIGURE 27: PREGNANCY AND FERTILITY TESTS
  • FIGURE 28: MNM DIVE-VENDOR COMPARISON MATRIX: URINALYSIS MARKET
  • FIGURE 29: MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: URINALYSIS MARKET
  • FIGURE 30: CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
  • FIGURE 31: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2017)
  • FIGURE 32: SIEMENS AG: COMPANY SNAPSHOT
  • FIGURE 33: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 124  
  • FIGURE 34: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 35: SYSMEX CORPORATION: COMPANY SNAPSHOT
  • FIGURE 36: QUIDEL CORPORATION: COMPANY SNAPSHOT
  • FIGURE 37: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
Back to Top